For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251118:nRSR8809Ha&default-theme=true
RNS Number : 8809H CVS Group plc 18 November 2025
18 November 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 17 November 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 17/11/2025
Aggregate number of Ordinary Shares purchased: 26,379
Lowest price paid per share (GBp): 1,130.00
Highest price paid per share (GBp): 1,144.00
Volume weighted average price paid per share (GBp): 1,136.95
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 71,290,112 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 71,290,112 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 450,671 Ordinary Shares in aggregate at a weighted average price
of 1,238.57 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
184 1140 17/11/2025 08:09:38 1334764783014121 XLON
430 1142 17/11/2025 09:05:20 1334764783020455 XLON
24 1140 17/11/2025 09:19:44 1334764783021518 XLON
49 1140 17/11/2025 09:19:44 1334764783021519 XLON
72 1140 17/11/2025 09:19:44 1334764783021520 XLON
69 1140 17/11/2025 09:19:44 1334764783021521 XLON
16 1140 17/11/2025 09:19:44 1334764783021522 XLON
698 1144 17/11/2025 10:14:06 1334764783025918 XLON
149 1144 17/11/2025 10:14:06 1334764783025919 XLON
76 1142 17/11/2025 10:26:43 1334764783026875 XLON
84 1142 17/11/2025 10:31:37 1334764783027404 XLON
489 1144 17/11/2025 10:40:23 1334764783028517 XLON
244 1144 17/11/2025 10:40:23 1334764783028518 XLON
817 1144 17/11/2025 10:48:52 1334764783029342 XLON
165 1144 17/11/2025 10:48:52 1334764783029343 XLON
432 1142 17/11/2025 10:51:30 1334764783029559 XLON
592 1142 17/11/2025 11:39:29 1334764783033730 XLON
89 1142 17/11/2025 11:39:29 1334764783033732 XLON
284 1142 17/11/2025 12:26:19 1334764783036985 XLON
16 1142 17/11/2025 12:26:19 1334764783036986 XLON
113 1142 17/11/2025 12:26:19 1334764783036989 XLON
561 1138 17/11/2025 12:40:36 1334764783037836 XLON
507 1138 17/11/2025 12:40:36 1334764783037837 XLON
76 1136 17/11/2025 13:10:10 1334764783040804 XLON
116 1136 17/11/2025 13:14:41 1334764783041124 XLON
991 1136 17/11/2025 13:14:41 1334764783041125 XLON
190 1138 17/11/2025 13:35:41 1334764783042857 XLON
937 1138 17/11/2025 13:51:08 1334764783044144 XLON
190 1138 17/11/2025 13:51:08 1334764783044147 XLON
190 1138 17/11/2025 13:51:08 1334764783044150 XLON
1609 1138 17/11/2025 13:51:08 1334764783044151 XLON
190 1138 17/11/2025 13:51:08 1334764783044152 XLON
190 1138 17/11/2025 13:51:08 1334764783044153 XLON
190 1138 17/11/2025 13:51:08 1334764783044154 XLON
190 1138 17/11/2025 13:51:08 1334764783044155 XLON
190 1138 17/11/2025 13:51:08 1334764783044156 XLON
190 1138 17/11/2025 13:51:08 1334764783044157 XLON
190 1138 17/11/2025 13:51:08 1334764783044158 XLON
190 1138 17/11/2025 13:51:08 1334764783044159 XLON
190 1138 17/11/2025 13:51:08 1334764783044160 XLON
617 1138 17/11/2025 13:51:08 1334764783044161 XLON
190 1138 17/11/2025 13:51:08 1334764783044162 XLON
110 1138 17/11/2025 13:51:08 1334764783044163 XLON
194 1138 17/11/2025 13:51:08 1334764783044164 XLON
190 1138 17/11/2025 13:51:09 1334764783044174 XLON
289 1138 17/11/2025 13:51:09 1334764783044177 XLON
5 1138 17/11/2025 13:51:09 1334764783044178 XLON
185 1138 17/11/2025 13:51:10 1334764783044179 XLON
29 1138 17/11/2025 13:51:10 1334764783044180 XLON
18 1138 17/11/2025 13:51:11 1334764783044182 XLON
43 1138 17/11/2025 13:51:11 1334764783044183 XLON
22 1138 17/11/2025 13:51:11 1334764783044184 XLON
18 1138 17/11/2025 13:51:11 1334764783044185 XLON
89 1138 17/11/2025 13:51:14 1334764783044186 XLON
42 1138 17/11/2025 13:51:14 1334764783044187 XLON
26 1138 17/11/2025 13:51:14 1334764783044189 XLON
164 1138 17/11/2025 13:51:16 1334764783044198 XLON
18 1138 17/11/2025 13:51:17 1334764783044200 XLON
172 1138 17/11/2025 13:51:19 1334764783044201 XLON
1994 1138 17/11/2025 13:51:19 1334764783044203 XLON
76 1136 17/11/2025 13:51:19 1334764783044208 XLON
990 1134 17/11/2025 14:10:36 1334764783046019 XLON
374 1134 17/11/2025 14:10:36 1334764783046020 XLON
547 1132 17/11/2025 14:13:15 1334764783046452 XLON
835 1132 17/11/2025 14:13:15 1334764783046453 XLON
1402 1130 17/11/2025 14:15:27 1334764783046723 XLON
17 1130 17/11/2025 14:15:27 1334764783046726 XLON
867 1130 17/11/2025 14:15:27 1334764783046727 XLON
17 1130 17/11/2025 14:15:27 1334764783046725 XLON
500 1130 17/11/2025 14:15:27 1334764783046724 XLON
76 1132 17/11/2025 14:31:46 1334764783048637 XLON
219 1132 17/11/2025 14:32:00 1334764783048711 XLON
243 1132 17/11/2025 14:32:00 1334764783048712 XLON
76 1136 17/11/2025 14:42:37 1334764783051049 XLON
1412 1136 17/11/2025 14:48:43 1334764783052311 XLON
1165 1136 17/11/2025 14:48:43 1334764783052313 XLON
257 1132 17/11/2025 14:52:36 1334764783053251 XLON
85 1132 17/11/2025 14:52:36 1334764783053252 XLON
266 1130 17/11/2025 15:15:55 1334764783057961 XLON
295 1136 17/11/2025 15:17:21 1334764783058239 XLON
76 1134 17/11/2025 15:17:30 1334764783058266 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSGPGWWGUPAGRM
Copyright 2019 Regulatory News Service, all rights reserved